Nature Medicine· Karen O’Leary·· 2026-10-15精选AI 评分73
光遗传疗法治疗晚期视网膜色素变性的初步小样本研究结果
Optogenetic therapy shows early promise for treating retinitis pigmentosa
AI 导读
一项针对晚期视网膜色素变性导致失明患者的小型研究显示,光遗传疗法安全性良好,初步疗效信号具有前景,并揭示了技术改进的机会。
推荐理由
小样本研究显示光遗传疗法对晚期视网膜色素变性安全,初步疗效信号提示技术改进空间。
正文 · 原文
Nature Medicine, Published online: 15 October 2026; doi:10.1038/d41591-026-00051-1
In a small study involving patients with blindness due to advanced retinitis pigmentosa, optogenetic therapy appears safe; early efficacy signals are promising and reveal opportunities for technical refinement.
来源:Nature Medicine · nature.com